Edition:
United States

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

16.82USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$16.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,703
52-wk High
$19.70
52-wk Low
$3.40

Chart for

About

Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic... (more)

Overall

Beta: --
Market Cap(Mil.): $663.15
Shares Outstanding(Mil.): 38.58
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 180.40 17.28
EPS (TTM): -- -- --
ROI: -- -0.52 35.61
ROE: -- -3.30 17.17

BRIEF-Rocket Pharmaceuticals Prices Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK

Jan 24 2018

BRIEF-Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Jan 23 2018

BRIEF-Tang Capital Partners Reports 8.1 Pct Passive Stake In Rocket Pharmaceuticals - SEC Filing

* TANG CAPITAL PARTNERS REPORTS 8.1 PCT PASSIVE STAKE IN ROCKET PHARMACEUTICALS INC AS OF JAN 4 - SEC FILING Source text: (http://bit.ly/2ra05Is) Further company coverage:

Jan 16 2018

Rocket Internet CEO says ready to pounce with cash pile

BERLIN Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

Jan 11 2018

INTERVIEW-Rocket Internet CEO says ready to pounce with cash pile

BERLIN, Jan 11 Germany's Rocket Internet needs to hold on to its mountain of cash so it can compete with rivals from the United States and China and pounce when investment opportunities arise, the chief executive said in an interview.

Jan 11 2018

Earnings vs. Estimates